Trump wants drugs made in the US. That's what LTP is planning on supplying, starting with Roxus next year.
Trump wants drugs made in the US Trump has repeatedly argued that major pharmaceutical firms should bring their production back home. His key targets include U.S. giants like Eli Lilly, Johnson & Johnson, and Pfizer.At the April 2 tariffs announcement, Trump claimed, “The U.S. no longer produces enough antibiotics.” He said this dependency on India and China must end.Ireland, in particular, came under fire from Trump for acting as a production base for brand-name drug ..
Industry pushback and strategic stockpilingBig Pharma isn’t taking the threat lightly.According to Reuters, major drugmakers have lobbied Trump to phase in the new rules gradually, giving them time to shift operations. Eli Lilly and others have since announced fresh investments to expand domestic manufacturing capacity. Novo Nordisk is also exploring ways to make more medicines in America.But building new facilities isn’t easy. Industry group PhRMA estimates that it can take 5 to 10 years and up to $2 billion to set up a plant that meets all regulatory requirements.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)